Home Medicine A comparison of two different assays for determining S-100B in serum and urine
Article
Licensed
Unlicensed Requires Authentication

A comparison of two different assays for determining S-100B in serum and urine

  • Magnus Hallén , Rickard Carlhed , Mathias Karlsson , Thomas Hallgren and Mikael Bergenheim
Published/Copyright: July 1, 2008

Abstract

Background: Brain injury after head trauma can be detected by S-100B measurements in serum. Recent preliminary studies indicate that urinary levels of S-100B are also increased after head injury, a finding that is of possible clinical value. The aims of the present study are two-fold: to compare serum measurements of two assays, the Liaison Sangtec®100 system and the Elecsys®S100 test, and to investigate to what extent they can detect and measure S-100B in urine.

Methods: A total of 191 serum and 174 urine samples from 107 patients (children aged between 1 and 18 years following head trauma) were measured with both assays. The results were compared using correlation analysis and Bland-Altman difference plots.

Results: Serum values of the Sangtec® system ranged from 0.02 to 2.28 μg/L, and from 0.005 to 2.13 μg/L for the Elecsys® test. Comparisons showed a clear correlation (correlation coefficient 0.80) but not an agreement between the methods. The Sangtec® system could only detect S-100B in 20 out of 174 urine samples (range 0.02–0.06 μg/L), whereas the Elecsys® test could detect S-100B in 171 samples (range 0.005–0.14 μg/L). No clear relation was observed between the two methods in urine analysis (correlation coefficient 0.60).

Conclusion: The Sangtec® and Elecsys® assays are not interchangeable methods when analyzing S-100B in serum or urine samples after head injury.

Clin Chem Lab Med 2008;46:1025–9.


Corresponding author: Mikael Bergenheim, MD, PhD, Associate Professor, Department of Surgery, Central Hospital Karlstad, Rosenborgsgatan, 651 85 Karlstad, Sweden Phone: +46-54-615672, Fax +46-54-158316,

Received: 2007-11-27
Accepted: 2008-3-20
Published Online: 2008-07-01
Published in Print: 2008-07-01

©2008 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. CCLM: Evolving to meet the needs of today's laboratory professionals and scientists
  3. Bacterial detection and blood product contamination
  4. Editorial: Rapid diagnostic tests to detect pathogenic microorganisms
  5. Reviews
  6. Rapid methods for diagnosis of bloodstream infections
  7. Validation criteria for nucleic acid amplification techniques for bacterial infections
  8. Incidence of bacterial transmission and transfusion reactions by blood components
  9. Strategies of bacteria screening in cellular blood components
  10. Methods for the detection of bacterial contamination in blood products
  11. Bacteria detection by flow cytometry
  12. Rapid screening by real-time 16S rDNA PCR for bacterial contamination of blood products
  13. Microbial safety of cell based medicinal products – what can we learn from cellular blood components?
  14. Genetics and Molecular Diagnostics
  15. Screening for genetic heterogeneity in the interferon sensitivity determining region of the hepatitis C virus genome by polymerase chain reaction with melting curve analysis
  16. Thiopurine S-methyltransferase (TPMT) pharmacogenetics: three new mutations and haplotype analysis in the Estonian population
  17. Genetic testing for adult-type hypolactasia in Italian families
  18. Improved real-time detection of the H63D and S65C mutations associated with hereditary hemochromatosis using a SimpleProbe assay format
  19. Easy detection of 5,10-methylenetetrahydrofolate reductase 1298A/C genotype by mutagenically separated PCR assay
  20. General Clinical Chemistry and Laboratory Medicine
  21. Mediterranean diet and plasma concentration of inflammatory markers in old and very old subjects in the ZINCAGE population study
  22. Plasma interleukin-1β, -6, -8 and tumor necrosis factor-α as highly informative markers of pelvic inflammatory disease
  23. The effect of hypothyroidism, hyperthyroidism, and their treatment on parameters of oxidative stress and antioxidant status
  24. Breath isoprene – aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study
  25. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration
  26. A comparison of two different assays for determining S-100B in serum and urine
  27. Diagnostic, clinical and laboratory turnaround times in troponin T testing
  28. Validation and Outcome Studies
  29. An international comparability study to determine the sources of uncertainty associated with a non-competitive sandwich fluorescent ELISA
  30. A new general regression-based approach for method comparison studies
  31. Letters to the Editor
  32. Procalcitonin values in preeclamptic women are related to severity of disease
  33. Cross-reactivity between λ antiserum and fibrinogen: a double trap in interpretation of serum protein electrophoresis
  34. Erroneous result of white blood cell differential count in a patient with mixed hyperlipidemia
  35. Lack of association of GH T1663A variation and IGFBP3–202A/C polymorphism with risk of ischemic stroke in Chinese
  36. Erratum
  37. Quality planning and analytical quality requirements derived from biology
Downloaded on 12.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2008.190/html
Scroll to top button